aluates Reports

$ 0.0

Automative

Global Anticancer Drugs Market Research Report 2026

Published Date: 2026-03-27

Report Code: QYRE-Auto-25M6948

Global Anticancer Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Anticancer Drugs Market Research Report 2026

Code: QYRE-Auto-25M6948

Report

2026-03-27

Pages:129

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Pfizer Inc

Amgen Inc

Astrazeneca plc

Merck

AbbVie

Johnson & Johnson

Gilead Sciences

Roche

Bristol–Myers Squibb

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

GSK

Exelixis Inc

Regeneron

Innovent

Hengrui Medicine

Johnson & Johnson

Anticancer Drugs Market Size

The global Anticancer Drugs market was valued at US$ 226980 million in 2025 and is anticipated to reach US$ 474170 million by 2032, at a CAGR of 11.3% from 2026 to 2032.

Anticancer Drugs Market

Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. Anticancer drugs are medications specifically designed to combat cancer by either inhibiting the growth of cancer cells or inducing their death. These drugs operate through various mechanisms, such as disrupting the cell cycle, interfering with specific signaling pathways crucial for cancer cell survival, or targeting the blood vessels that support tumor growth. Anticancer drugs encompass a diverse range of classes, including cytotoxic drugs, targeted therapies, hormone therapies, immunotherapies, and angiogenesis inhibitors. The selection of these drugs depends on the type of cancer, its stage, and individual patient characteristics. While these medications play a crucial role in cancer treatment, they may also have side effects due to their impact on rapidly dividing normal cells.

Global key players of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, etc. The top five players hold a share over 55%. North America is the largest market, and has a share about 55%, followed by Asia-Pacific and Europe with share 21% and 19%, separately. In terms of product type, Targeted Therapy is the largest segment, occupied for a share of 58%. In terms of application, Blood-related Cancer has a share about 23 percent.

This report delivers a comprehensive overview of the global Anticancer Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anticancer Drugs. The Anticancer Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Anticancer Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Anticancer Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Anticancer Drugs Market Report

Report Metric	Details
Report Name	Anticancer Drugs Market
Accounted market size in 2025	US$ 226980 million
Forecasted market size in 2032	US$ 474170 million
CAGR	11.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Cancer Immunotherapy Targeted Therapy Chemotherapy Other
Segment by Application	Lung Cancer Breast Cancer Prostate Cancer Blood-related Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anticancer Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Anticancer Drugs Market growing?

Ans: The Anticancer Drugs Market witnessing a CAGR of 11.3% during the forecast period 2026-2032.

What is the Anticancer Drugs Market size in 2032?

Ans: The Anticancer Drugs Market size in 2032 will be US$ 474170 million.

What is the market share of major companies in Anticancer Drugs Market?

Ans: The top five players hold a share over 55%.

What is the Anticancer Drugs Market share by region?

Ans: North America is the largest market, and has a share about 55%, followed by Asia-Pacific and Europe with share 21% and 19%, separately.

What is the Anticancer Drugs Market share by type?

Ans: In terms of product type, Targeted Therapy is the largest segment, occupied for a share of 58%.

Who are the main players in the Anticancer Drugs Market report?

Ans: The main players in the Anticancer Drugs Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Anticancer Drugs Market report?

Ans: The Applications covered in the Anticancer Drugs Market report are Lung Cancer, Breast Cancer, Prostate Cancer, Blood-related Cancer, Other

What are the Type segmentation covered in the Anticancer Drugs Market report?

Ans: The Types covered in the Anticancer Drugs Market report are Cancer Immunotherapy, Targeted Therapy, Chemotherapy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anticancer Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Cancer Immunotherapy

1.2.3 Targeted Therapy

1.2.4 Chemotherapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Anticancer Drugs Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Prostate Cancer

1.3.5 Blood-related Cancer

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anticancer Drugs Market Perspective (2021–2032)

2.2 Global Anticancer Drugs Growth Trends by Region

2.2.1 Global Anticancer Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Anticancer Drugs Historic Market Size by Region (2021–2026)

2.2.3 Anticancer Drugs Forecasted Market Size by Region (2027–2032)

2.3 Anticancer Drugs Market Dynamics

2.3.1 Anticancer Drugs Industry Trends

2.3.2 Anticancer Drugs Market Drivers

2.3.3 Anticancer Drugs Market Challenges

2.3.4 Anticancer Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Anticancer Drugs Players by Revenue

3.1.1 Global Top Anticancer Drugs Players by Revenue (2021–2026)

3.1.2 Global Anticancer Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Anticancer Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Anticancer Drugs Revenue

3.4 Global Anticancer Drugs Market Concentration Ratio

3.4.1 Global Anticancer Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anticancer Drugs Revenue in 2025

3.5 Global Key Players of Anticancer Drugs Head Offices and Areas Served

3.6 Global Key Players of Anticancer Drugs, Products and Applications

3.7 Global Key Players of Anticancer Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Anticancer Drugs Breakdown Data by Type

4.1 Global Anticancer Drugs Historic Market Size by Type (2021–2026)

4.2 Global Anticancer Drugs Forecasted Market Size by Type (2027–2032)

5 Anticancer Drugs Breakdown Data by Application

5.1 Global Anticancer Drugs Historic Market Size by Application (2021–2026)

5.2 Global Anticancer Drugs Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Anticancer Drugs Market Size (2021–2032)

6.2 North America Anticancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Anticancer Drugs Market Size by Country (2021–2026)

6.4 North America Anticancer Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Anticancer Drugs Market Size (2021–2032)

7.2 Europe Anticancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Anticancer Drugs Market Size by Country (2021–2026)

7.4 Europe Anticancer Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Anticancer Drugs Market Size (2021–2032)

8.2 Asia-Pacific Anticancer Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Anticancer Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Anticancer Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Anticancer Drugs Market Size (2021–2032)

9.2 Latin America Anticancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Anticancer Drugs Market Size by Country (2021–2026)

9.4 Latin America Anticancer Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Anticancer Drugs Market Size (2021–2032)

10.2 Middle East & Africa Anticancer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Anticancer Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Anticancer Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Anticancer Drugs Introduction

11.1.4 AbbVie Revenue in Anticancer Drugs Business (2021–2026)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Anticancer Drugs Introduction

11.2.4 Johnson & Johnson Revenue in Anticancer Drugs Business (2021–2026)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Anticancer Drugs Introduction

11.3.4 Novartis Revenue in Anticancer Drugs Business (2021–2026)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Anticancer Drugs Introduction

11.4.4 Gilead Sciences Revenue in Anticancer Drugs Business (2021–2026)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Anticancer Drugs Introduction

11.5.4 Roche Revenue in Anticancer Drugs Business (2021–2026)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Anticancer Drugs Introduction

11.6.4 Bristol-Myers Squibb Revenue in Anticancer Drugs Business (2021–2026)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Details

11.7.2 Amgen Business Overview

11.7.3 Amgen Anticancer Drugs Introduction

11.7.4 Amgen Revenue in Anticancer Drugs Business (2021–2026)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Anticancer Drugs Introduction

11.8.4 AstraZeneca Revenue in Anticancer Drugs Business (2021–2026)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Details

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Anticancer Drugs Introduction

11.9.4 Merck & Co Revenue in Anticancer Drugs Business (2021–2026)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Anticancer Drugs Introduction

11.10.4 Takeda Revenue in Anticancer Drugs Business (2021–2026)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Anticancer Drugs Introduction

11.11.4 Merck KGaA Revenue in Anticancer Drugs Business (2021–2026)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Details

11.12.2 Seagen Business Overview

11.12.3 Seagen Anticancer Drugs Introduction

11.12.4 Seagen Revenue in Anticancer Drugs Business (2021–2026)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Anticancer Drugs Introduction

11.13.4 Eli Lilly Revenue in Anticancer Drugs Business (2021–2026)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Details

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Anticancer Drugs Introduction

11.14.4 Ono Pharmaceutical Revenue in Anticancer Drugs Business (2021–2026)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Details

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Anticancer Drugs Introduction

11.15.4 Pfizer Revenue in Anticancer Drugs Business (2021–2026)

11.15.5 Pfizer Recent Development

11.16 GSK

11.16.1 GSK Company Details

11.16.2 GSK Business Overview

11.16.3 GSK Anticancer Drugs Introduction

11.16.4 GSK Revenue in Anticancer Drugs Business (2021–2026)

11.16.5 GSK Recent Development

11.17 Exelixis

11.17.1 Exelixis Company Details

11.17.2 Exelixis Business Overview

11.17.3 Exelixis Anticancer Drugs Introduction

11.17.4 Exelixis Revenue in Anticancer Drugs Business (2021–2026)

11.17.5 Exelixis Recent Development

11.18 Regeneron

11.18.1 Regeneron Company Details

11.18.2 Regeneron Business Overview

11.18.3 Regeneron Anticancer Drugs Introduction

11.18.4 Regeneron Revenue in Anticancer Drugs Business (2021–2026)

11.18.5 Regeneron Recent Development

11.19 Innovent

11.19.1 Innovent Company Details

11.19.2 Innovent Business Overview

11.19.3 Innovent Anticancer Drugs Introduction

11.19.4 Innovent Revenue in Anticancer Drugs Business (2021–2026)

11.19.5 Innovent Recent Development

11.20 Hengrui Medicine

11.20.1 Hengrui Medicine Company Details

11.20.2 Hengrui Medicine Business Overview

11.20.3 Hengrui Medicine Anticancer Drugs Introduction

11.20.4 Hengrui Medicine Revenue in Anticancer Drugs Business (2021–2026)

11.20.5 Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Pfizer Inc

Amgen Inc

Astrazeneca plc

Merck

AbbVie

Johnson & Johnson

Gilead Sciences

Roche

Bristol–Myers Squibb

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

GSK

Exelixis Inc

Regeneron

Innovent

Hengrui Medicine

Johnson & Johnson

List of Tables

Table 1. Global Anticancer Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Cancer Immunotherapy

Table 3. Key Players of Targeted Therapy

Table 4. Key Players of Chemotherapy

Table 5. Key Players of Other

Table 6. Global Anticancer Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Anticancer Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Anticancer Drugs Market Size by Region (US$ Million), 2021–2026

Table 9. Global Anticancer Drugs Market Share by Region (2021–2026)

Table 10. Global Anticancer Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Anticancer Drugs Market Share by Region (2027–2032)

Table 12. Anticancer Drugs Market Trends

Table 13. Anticancer Drugs Market Drivers

Table 14. Anticancer Drugs Market Challenges

Table 15. Anticancer Drugs Market Restraints

Table 16. Global Anticancer Drugs Revenue by Players (US$ Million), 2021–2026

Table 17. Global Anticancer Drugs Market Share by Players (2021–2026)

Table 18. Global Top Anticancer Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anticancer Drugs Revenue, 2025

Table 19. Ranking of Global Top Anticancer Drugs Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Anticancer Drugs Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Anticancer Drugs, Headquarters and Area Served

Table 22. Global Key Players of Anticancer Drugs, Products and Applications

Table 23. Global Key Players of Anticancer Drugs, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Anticancer Drugs Market Size by Type (US$ Million), 2021–2026

Table 26. Global Anticancer Drugs Revenue Market Share by Type (2021–2026)

Table 27. Global Anticancer Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Anticancer Drugs Revenue Market Share by Type (2027–2032)

Table 29. Global Anticancer Drugs Market Size by Application (US$ Million), 2021–2026

Table 30. Global Anticancer Drugs Revenue Market Share by Application (2021–2026)

Table 31. Global Anticancer Drugs Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Anticancer Drugs Revenue Market Share by Application (2027–2032)

Table 33. North America Anticancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Anticancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 35. North America Anticancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Anticancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Anticancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Anticancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Anticancer Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Anticancer Drugs Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Anticancer Drugs Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Anticancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Anticancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Anticancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Anticancer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Anticancer Drugs Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Anticancer Drugs Market Size by Country (US$ Million), 2027–2032

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Anticancer Drugs Product

Table 51. AbbVie Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 52. AbbVie Recent Development

Table 53. Johnson & Johnson Company Details

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Anticancer Drugs Product

Table 56. Johnson & Johnson Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 57. Johnson & Johnson Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Anticancer Drugs Product

Table 61. Novartis Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 62. Novartis Recent Development

Table 63. Gilead Sciences Company Details

Table 64. Gilead Sciences Business Overview

Table 65. Gilead Sciences Anticancer Drugs Product

Table 66. Gilead Sciences Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 67. Gilead Sciences Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Anticancer Drugs Product

Table 71. Roche Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 72. Roche Recent Development

Table 73. Bristol-Myers Squibb Company Details

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb Anticancer Drugs Product

Table 76. Bristol-Myers Squibb Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 77. Bristol-Myers Squibb Recent Development

Table 78. Amgen Company Details

Table 79. Amgen Business Overview

Table 80. Amgen Anticancer Drugs Product

Table 81. Amgen Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 82. Amgen Recent Development

Table 83. AstraZeneca Company Details

Table 84. AstraZeneca Business Overview

Table 85. AstraZeneca Anticancer Drugs Product

Table 86. AstraZeneca Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 87. AstraZeneca Recent Development

Table 88. Merck & Co Company Details

Table 89. Merck & Co Business Overview

Table 90. Merck & Co Anticancer Drugs Product

Table 91. Merck & Co Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 92. Merck & Co Recent Development

Table 93. Takeda Company Details

Table 94. Takeda Business Overview

Table 95. Takeda Anticancer Drugs Product

Table 96. Takeda Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 97. Takeda Recent Development

Table 98. Merck KGaA Company Details

Table 99. Merck KGaA Business Overview

Table 100. Merck KGaA Anticancer Drugs Product

Table 101. Merck KGaA Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 102. Merck KGaA Recent Development

Table 103. Seagen Company Details

Table 104. Seagen Business Overview

Table 105. Seagen Anticancer Drugs Product

Table 106. Seagen Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 107. Seagen Recent Development

Table 108. Eli Lilly Company Details

Table 109. Eli Lilly Business Overview

Table 110. Eli Lilly Anticancer Drugs Product

Table 111. Eli Lilly Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 112. Eli Lilly Recent Development

Table 113. Ono Pharmaceutical Company Details

Table 114. Ono Pharmaceutical Business Overview

Table 115. Ono Pharmaceutical Anticancer Drugs Product

Table 116. Ono Pharmaceutical Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 117. Ono Pharmaceutical Recent Development

Table 118. Pfizer Company Details

Table 119. Pfizer Business Overview

Table 120. Pfizer Anticancer Drugs Product

Table 121. Pfizer Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 122. Pfizer Recent Development

Table 123. GSK Company Details

Table 124. GSK Business Overview

Table 125. GSK Anticancer Drugs Product

Table 126. GSK Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 127. GSK Recent Development

Table 128. Exelixis Company Details

Table 129. Exelixis Business Overview

Table 130. Exelixis Anticancer Drugs Product

Table 131. Exelixis Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 132. Exelixis Recent Development

Table 133. Regeneron Company Details

Table 134. Regeneron Business Overview

Table 135. Regeneron Anticancer Drugs Product

Table 136. Regeneron Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 137. Regeneron Recent Development

Table 138. Innovent Company Details

Table 139. Innovent Business Overview

Table 140. Innovent Anticancer Drugs Product

Table 141. Innovent Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 142. Innovent Recent Development

Table 143. Hengrui Medicine Company Details

Table 144. Hengrui Medicine Business Overview

Table 145. Hengrui Medicine Anticancer Drugs Product

Table 146. Hengrui Medicine Revenue in Anticancer Drugs Business (US$ Million), 2021–2026

Table 147. Hengrui Medicine Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Anticancer Drugs Picture

Figure 2. Global Anticancer Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Anticancer Drugs Market Share by Type: 2025 vs 2032

Figure 4. Cancer Immunotherapy Features

Figure 5. Targeted Therapy Features

Figure 6. Chemotherapy Features

Figure 7. Other Features

Figure 8. Global Anticancer Drugs Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Anticancer Drugs Market Share by Application: 2025 vs 2032

Figure 10. Lung Cancer Case Studies

Figure 11. Breast Cancer Case Studies

Figure 12. Prostate Cancer Case Studies

Figure 13. Blood-related Cancer Case Studies

Figure 14. Other Case Studies

Figure 15. Anticancer Drugs Report Years Considered

Figure 16. Global Anticancer Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Anticancer Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Anticancer Drugs Market Share by Region: 2025 vs 2032

Figure 19. Global Anticancer Drugs Market Share by Players in 2025

Figure 20. Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Anticancer Drugs Revenue in 2025

Figure 22. North America Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Anticancer Drugs Market Share by Country (2021–2032)

Figure 24. United States Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Anticancer Drugs Market Share by Country (2021–2032)

Figure 28. Germany Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Anticancer Drugs Market Share by Region (2021–2032)

Figure 36. China Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Anticancer Drugs Market Share by Country (2021–2032)

Figure 44. Mexico Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Anticancer Drugs Market Share by Country (2021–2032)

Figure 48. Israel Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Anticancer Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. AbbVie Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 52. Johnson & Johnson Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 53. Novartis Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 54. Gilead Sciences Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 55. Roche Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 57. Amgen Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 58. AstraZeneca Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 59. Merck & Co Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 60. Takeda Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 61. Merck KGaA Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 62. Seagen Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 63. Eli Lilly Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 64. Ono Pharmaceutical Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 65. Pfizer Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 66. GSK Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 67. Exelixis Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 68. Regeneron Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 69. Innovent Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 70. Hengrui Medicine Revenue Growth Rate in Anticancer Drugs Business (2021–2026)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Cancer Treatment Drugs Market

Global Targeted Chemotherapy Drugs Market Research Report 2024

Global Antiangiogenic Drugs Market Research Report 2024

Global Targeted Antitumor Drugs Market Research Report 2025

Platinum Anti tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024

Global Metastatic Cancer Treat Drug Market Research Report 2025

Global Anti Neoplastic Pharmaceutical Agents Market Insights Forecast to 2030

Global Targeted Oncology Drugs Market Research Report 2024

Global Anti tumor Injection Market Research Report 2024

Global Anti VEGF Therapy for Cancer Market Research Report 2024

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Cancer Targeted Drug Market Research Report 2025

Global Alkylating Agent Antineoplastic Drugs Market Research Report 2024

Global Breast Cancer Drugs Market Insights Forecast to 2030

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Targeted Cancer Therapy Market Research Report 2024

Global Stomach Cancer Drugs Market Insights Forecast to 2030

Global Targeted Small Molecule Drug Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions